Judge Excludes Accutane Maker's Own Assessments

Law360, New York (May 4, 2007, 12:00 AM EDT) -- The manufacturer of the acne drug Accutane scored a victory Wednesday, when Judge James S. Moody, Jr. granted its hotly contested motion to exclude any evidence related to “causality assessments” that address Accutane’s potential to cause inflammatory bowel disease.

The plaintiffs, who are Accutane users suing for damages, had wanted to use these assessments as evidence of Accutane’s maleficent side effects, and as proof that Hoffmann-LaRoche, Accutane’s manufacturer, was aware of them.

Hoffmann-LaRoche has been sidled by about 400 complaints in the U.S. that allege that...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.